2026-08-18T10:46:02-05:00 2025-12-31 593204548 JAMES MOORE & CO PL 5931 NW 1ST PL GAINESVILLE FL 326072063 990 2025-01-01 593471957 FOUNDATION FOR APPLIED MOLECULAR EVOLUTION INC FOUN 3864188085 13709 PROGRESS BLVD 7 ALACHUA FL 326159495 STEVEN BENNER BOARD CHAIRMAN & CEO 3864188085 2026-08-13 1 CORINNE LAROCHE P01500189 3523781331 2026-08-13 2025 2025-03-06 01:10:19Z STEVEN BENNER 13709 PROGRESS BLVD 7 ALACHUA FL 326159495 4128654 0 X WWW.FFAME.ORG X 1997 FL THE FOUNDATION PROVIDES AN INNOVATIVE ENVIRONMENT TO HOST THE SCIENTIFIC AND TECHNOLOGICAL RESEARCH OF A SMALL GROUP OF SELECTED MOLECULAR AND LIFE SCIENTISTS TO MEET OPPORTUNITIES IN COMMERCE AND MEDICINE. 4 2 36 6 0 0 3823695 2733939 360144 0 568495 904814 3198 97 4755532 3638850 180954 32329 0 0 2277948 2131843 0 0 0 1374859 1088570 3833761 3252742 921771 386108 2672498 2727025 62926 416428 2609572 2310597 THE FOUNDATION PROVIDES AN INNOVATIVE ENVIRONMENT TO HOST THE SCIENTIFIC AND TECHNOLOGICAL RESEARCH OF A SMALL GROUP OF SELECTED MOLECULAR AND LIFE SCIENTISTS TO MEET OPPORTUNITIES IN COMMERCE AND MEDICINE. 0 0 2492480 32329 97 THE ORGANIZATION HAS CONDUCTED A NUMBER OF RESEARCH PROJECTS.1R01AI135146-01A1 DIAGNOSTICS AND SURVEILLANCE FOR LOW-RESOURCE ENVIRONMENTS. THE AIMS OF THIS PROJECT ARE TO EXPLORE AND DEVELOP FASTER AND LESS EXPENSIVE DIAGNOSTICS TOOLS AND TO INCREASE THE ROBUSTNESS OF MULTIPLEX PATHOGEN DETECTION PRODUCTS.1R61CA291117-01 EVOLVED MOLECULES THAT DESTROY CANCER RELEVANT PROTEINS. THE TECHNOLOGY TO BE DEVELOPED HERE WILL CREATE A NEW CAPABILITY, REAGENTS THAT NOT ONLY BIND A TARGET PROTEIN, BUT ALSO CLEAVE IT, TO BE AVAILABLE FROM SUPPLIERS IN WEEKS (NOT MONTHS) AT 10-100 FOLD LOWER COST THAN ANTIBODIES. 2492480 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 1 0 0 0 1 1 0 0 0 0 1 0 0 0 1 13 0 1 36 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 2 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 X THE ORGANIZATION 3864188085 13709 PROGRESS BLVD 7 ALACHUA FL 326159495 STEVEN BENNER BOARD CHAIR & CEO 32.00 8.00 X X 150000 30000 720 NIGEL RICHARDS DIRECTOR 1.00 0.00 X 38275 0 0 ANDREW ELLINGTON DIRECTOR 1.00 0.00 X 1000 0 0 ERIC GAUCHER DIRECTOR 1.00 0.00 X 1000 0 0 190275 30000 720 1 0 1 0 NUCLEIC ACIDS LICENSING LLC 13709 PROGRESS BLVD BOX 35 ALACHUA FL 32615 RENT - OPERATING LEASE 234443 1 1664278 1069661 1069661 2733939 74271 74271 1320347 489804 830543 830543 830543 MISCELLANEOUS REVENUE 541700 97 97 97 3638850 97 0 904814 32329 32329 190996 49520 141476 1677896 1501328 176568 122089 101872 20217 140862 116930 23932 5885 772 5113 84079 11030 73049 42675 5598 37077 38702 15090 23612 12728 3922 8806 283291 166776 116515 32108 29737 2371 83522 83522 LABORATORY SUPPLIES 444648 421496 23152 RENTAL AND MAINTENANCE 31648 31648 LICENSES AND FEES 17494 4432 13062 BAD DEBT EXPENSE 11790 11790 3252742 2492480 760262 0 463783 159936 48175 13951 193930 208895 14000 0 1201009 1051698 196279 149311 1753256 1957210 3075 237722 2672498 2727025 62926 80595 100000 0 235833 62926 416428 X 2609572 2310597 2609572 2310597 2672498 2727025 386108 -685083 0 X 0 1 X 0 1 1 X 2365143 3156730 3462759 3823695 2733939 15542266 2365143 3156730 3462759 3823695 2733939 15542266 2672041 12870225 53104 48841 57592 66671 74271 300479 15842745 770182 0.81240 0.78790 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1201009 1051698 149311 149311 DEPOSITS 3075 OPERATING LEASE RIGHT-OF-USE ASSETS 234647 237722 OPERATING LEASE RIGHT-OF-USE LIABILITIES 235833 235833 X 2953767 -685083 -685083 3638850 0 3638850 3252742 0 3252742 0 3252742 PART X, LINE 2: THE FOUNDATION IS A NOT-FOR-PROFIT ORGANIZATION THAT IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE. MANAGEMENT BELIEVES THE FOUNDATION CONTINUES TO SATISFY THE REQUIREMENTS OF A TAX-EXEMPT ORGANIZATION AS OF DECEMBER 31, 2025. 1 INDIANA UNIVERSITY 509 EAST 3RD STREET BLOOMINGTON IN 474013654 356001673 115(1) 32329 0 RESEARCH 1 0 PART I, LINE 2: THE SUBRECIPIENT GRANTS ARE AN INTEGRAL PART OF THE PROGRAM ACTIVITIES OF FFAME. AS SUCH, THE USAGE OF THE FUNDS ARE CLOSELY MONITORED TO ENSURE THE FUNDS ARE SPENT APPROPRIATELY. X X 0 0 0 0 0 0 0 0 0 STEVEN BENNER BOARD CHAIR & CEO 150000 30000 0 0 0 0 0 0 720 0 150720 30000 0 0 STEVEN BENNER BOARD CHAIR & CEO SHORT-TERM LOAN DUE TO ERRONEOUS DEPOSIT X 100000 100000 0 0 0 100000 NUCLEIC ACIDS LICENSING LLC BOARD CHAIR & CEO STEVEN BENNER IS >35% OWNER 234443 RENT EXPENSE 0 X 1 1069661 FMV 0 0 0 0 PART I, COLUMN (B): THE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTORS. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF FORM 990 WILL BE PROVIDED TO THE GOVERNING BODY BEFORE IT IS FILED WITH THE IRS. IT WILL BE REVIEWED AND ANY NECESSARY REVISIONS WILL BE MADE. FORM 990, PART VI, SECTION B, LINE 12C AT THE ANNUAL BOARD MEETING, BOARD MEMBERS ARE PROVIDED THE CONFLICT OF INTEREST POLICY. THE BOARD MEMBERS MUST SIGN ACKNOWLEDGMENT OF RECEIPT OF THE POLICY. IF CONFLICTS ARISE DURING THE YEAR, THE BOARD MEMBERS ARE AWARE OF THEIR NEED TO DISCLOSE. FORM 990, PART VI, SECTION B, LINE 15 A BOARD MEETING IS CALLED TO REVIEW PERFORMANCE FOR THE PRIOR YEAR. BOARD MEMBERS DETERMINE ANY INCREASE AND VOTE ON THE INCREASE DETERMINED. THE APPLICABLE INCREASE IS APPLIED ONCE IT IS VOTED ON AND APPROVED BY THE BOARD. THE AMOUNT IS BASED ON NIH GUIDELINES FOR PI'S. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST. NUCLEIC ACIDS LICENSINGLLC 1501 NW 68TH TERRACE GAINESVILLE FL 32605 202709991 RESEARCH FL N/A C 0 FIREBIRD BIOMOLECULAR SCIENCES LLC 13709 PROGRESS BLVD N104 ALACHUA FL 32615 900355722 RESEARCH FL N/A S 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 1 0 0